Q&A: What role does corneal hysteresis play in determining glaucoma risk?

Video

Thomas A. Wong, OD, FNAP, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, discuss corneal hysteresis: part three.

Ahead of his technology article in the July 2022 issue of Optometry Times®, Thomas A. Wong, OD, FNAP, associate clinical professor of SUNY Optometry, and his co-authors Elise Regina, OD, and Kelly Armstrong, OD, both members of the SUNY Optometry class of 2022, discuss corneal hysteresis.

Related: Q&A: What is corneal hysteresis?

This transcript has been lightly edited for clarity:

What role does corneal hysteresis play in determining glaucoma risk?

Elise Regina, OD:

So the current risk factors that we all know right now..., the main five are old age, high IOP, CD ratio, high pattern standard deviation, and a thinner central corneal thickness. And also things that we consider in clinic include race, family history, the quality of the testing that we're getting and how long the patient has been followed for these things.

Related: Q&A: How is corneal hysteresis measured?

So earlier intervention is always better for these glaucoma patients, especially to prevent any permanent damage or vision loss. So when we're talking about corneal hysteresis, it just can be another one of all of these factors that we take into account when we're diagnosing and monitoring our patients for progression.

It's still unclear how exactly corneal hysteresis is related to glaucoma. But it also may be a new independent risk factor for glaucoma that we as practitioners can use when we're diagnosing and treating our patients. Since the corneal hysteresis doesn't directly affect the IOP measurements the way the central corneal thickness does, it makes the association with the IOP minimal, which is a good thing for us.

Related: Corneal hysteresis and biomechanics growing in diagnostic importance

So this literature is hypothesizing that the hysteresis may be a biomarker for the biomechanical properties of these tissues, and therefore the low corneal hysteresis readings would increase the risk for glaucomatous damage with IOP peaks and fluctuations.

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Recent Videos
Dana Shannon, OD, FAAO, detailed a lecture she gave at the NOA Midwestern Symposium earlier this month.
CRU 2025 provided the latest insights regarding glaucoma, dry eye disease, retina, myopia, neurotrophic keratitis, and keratoconus.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, gave 2 presentations alongside other ODs and MDs at CRU 2025.
Melissa Tawa, OD, FAAO, provides insights to take glaucoma management from reactive to proactive in presentations given at CRU 2025 in Napa, California.
Jennifer Li, MD, details a talk she gave alongside Melissa Barnett, OD, FAAO, FSLS, FBCLA, at CRU 2025 in Napa, California.
Deb Ristvedt, DO, details a handful of presentations on glaucoma she gave during CRU 2025 in Napa, California.
Melissa Barnett, OD, FAAO, FSLS, FBCLA, discusses keratoconus management, diagnosis, and other key insights at CRU 2025.
Cecelia Koetting, OD, FAAO, DipABO, details a talk she gave among optometrists and ophthalmologists at CRU 2025.
Ali Tafreshi sits down with Optometry Times to discuss Topcon's "Healthcare from the Eye" initiative.
Nora Lee Cothran, OD, FAAO, details a real-world study that found IOP-lowering benefits when switching patients with glaucoma to latanoprostene bunod treatment.
© 2025 MJH Life Sciences

All rights reserved.